
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $283.7M | -- | -- | $0.33 | -- |
07/31/2025 | Q2 | $275.3M | -- | -- | -- | -- |
05/06/2025 | Q1 | $260M | $269.7M | -$0.15 | $0.20 | -$0.35 |
02/06/2025 | Q4 | $300M | $306.9M | $0.34 | $0.58 | -$0.24 |
10/30/2024 | Q3 | $280.5M | $282.4M | $0.19 | $0.42 | -$0.23 |
08/01/2024 | Q2 | $254.4M | $276.8M | $0.08 | $0.14 | -$0.06 |
05/02/2024 | Q1 | $236.8M | $246.2M | -$0.34 | -$0.09 | -$0.25 |
02/08/2024 | Q4 | $255.6M | $258.8M | -$0.32 | $0.15 | -$0.47 |
11/02/2023 | Q3 | -- | -- | $0.12 | $0.48 | -$0.36 |
08/01/2023 | Q2 | -- | -- | $0.08 | $0.28 | -$0.20 |
05/02/2023 | Q1 | -- | -- | -$0.33 | $0.06 | -$0.39 |
02/28/2023 | Q4 | -- | -- | -$0.64 | $0.08 | -$0.72 |
11/02/2022 | Q3 | -- | -- | $0.37 | $0.95 | -$0.58 |
08/04/2022 | Q2 | -- | -- | $0.20 | $0.85 | -$0.65 |
04/28/2022 | Q1 | -- | -- | $0.17 | $0.68 | -$0.51 |
02/14/2022 | Q4 | -- | -- | $0.28 | $0.92 | -$0.64 |
11/02/2021 | Q3 | -- | -- | $0.61 | $0.91 | -$0.30 |
07/29/2021 | Q2 | -- | -- | $0.43 | $0.83 | -$0.40 |
04/29/2021 | Q1 | -- | -- | $0.30 | $0.66 | -$0.36 |
02/01/2021 | Q4 | -- | -- | $0.37 | $0.82 | -$0.45 |
10/27/2020 | Q3 | -- | -- | $0.20 | $0.49 | -$0.29 |
07/28/2020 | Q2 | -- | -- | -$0.10 | $0.23 | -$0.33 |
05/07/2020 | Q1 | -- | -- | $0.26 | $0.51 | -$0.25 |
02/06/2020 | Q4 | -- | -- | $0.51 | $0.78 | -$0.27 |
10/24/2019 | Q3 | -- | -- | $0.46 | $0.71 | -$0.25 |
07/25/2019 | Q2 | -- | -- | -- | $0.63 | -- |
04/25/2019 | Q1 | -- | -- | -- | $0.41 | -- |
02/07/2019 | Q4 | -- | -- | -- | $0.67 | -- |
10/25/2018 | Q3 | -- | -- | -- | $0.56 | -- |
07/26/2018 | Q2 | -- | -- | -- | -- | -- |
04/26/2018 | Q1 | -- | -- | -- | -- | -- |
02/01/2018 | Q4 | -- | -- | -- | -- | -- |
10/26/2017 | Q3 | -- | -- | -- | -- | -- |
07/27/2017 | Q2 | -- | -- | -- | -- | -- |
05/04/2017 | Q1 | -- | -- | -- | -- | -- |
02/15/2017 | Q4 | -- | -- | -- | -- | -- |
10/27/2016 | Q3 | -- | -- | -- | -- | -- |
07/28/2016 | Q2 | -- | -- | -- | -- | -- |
04/28/2016 | Q1 | -- | -- | -- | -- | -- |
02/04/2016 | Q4 | -- | -- | -- | -- | -- |
10/29/2015 | Q3 | -- | -- | -- | -- | -- |
Omnicell reported $269.7M worth of top line sales in its most recent quarter.
Omnicell announced earnings per share of -$0.15 which represents a miss of analyst forecast a $0.20 per share.
Omnicell reported $110.9M that represents $2.38 per share over the last quarter.
Omnicell's earnings are forecast to grow from $0.27 per share to $1.69 per share next year representing an increase of 324.14%.
Omnicell's next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.